Stillings M R, England C D, Welbourn A P, Smith C F
J Med Chem. 1986 Sep;29(9):1780-3. doi: 10.1021/jm00159a037.
We have recently reported the synthesis and alpha 2-antagonist activity of the methoxy derivative 2 [2-(2-methoxy-1,4-benzodioxan-2-yl)-2-imidazoline] and described the enhanced potency of this compound over the parent 1,4-benzodioxan, idazoxan, in reversing the inhibition caused by alpha 2-adrenoreceptor agonists of the electrically induced twitch in the rat or mouse vas deferens. It was of interest to us to discover whether a similar substitution in the structurally related alpha 2-adrenoreceptor antagonists piperoxan, prosympal, and fenmetazole would similarly enhance potency. We subsequently discovered that this was not so and potency was decreased markedly. In particular, that of the methoxy derivative of piperoxan was ca. 220 times less than the parent structure.
我们最近报道了甲氧基衍生物2 [2-(2-甲氧基-1,4-苯并二恶烷-2-基)-2-咪唑啉]的合成及其α2拮抗剂活性,并描述了该化合物相对于母体1,4-苯并二恶烷、咪唑克生在逆转α2肾上腺素能受体激动剂对大鼠或小鼠输精管电诱发抽搐的抑制作用方面增强的效力。我们感兴趣的是,在结构相关的α2肾上腺素能受体拮抗剂哌罗克生、普西泮和芬美唑中进行类似取代是否会同样增强效力。随后我们发现并非如此,效力显著降低。特别是,哌罗克生的甲氧基衍生物的效力约比母体结构低220倍。